stockrowGuardant Health, Inc.
GH Healthcare Diagnostics & Research
Guardant Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $982.0 million, up 32.9% from fiscal 2024.
- Revenue
- +36.1%
- EPS
- −25.7%
- Free cash flow
- +18.7%
- Total debt
- +34.8%
Quarter to September 2026, against a year earlier
Follow GH
Alert me
Guardant Health, Inc. (GH) Shares outstanding
Guardant Health, Inc.'s shares outstanding at the end of fiscal 2025 was $125.4M, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $134.4M. Over the past ten years it has ranged from $12.6M (fiscal 2017) to $125.4M (fiscal 2025) — the current reading is the highest in ten years. Guardant Health, Inc. ranks 12th of 49 Diagnostics & Research companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $125.4M | 2.14% |
| FY2024 | $122.7M | 9.61% |
| FY2023 | $112.0M | 9.60% |
| FY2022 | $102.2M | 0.85% |
| FY2021 | $101.3M | 3.91% |
| FY2020 | $97.5M | 7.62% |
| FY2019 | $90.6M | 197.99% |
| FY2018 | $30.4M | 141.64% |
| FY2017 | $12.6M | (3.61%) |
| FY2016 | $13.1M | — |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $134.4M | 1.17% |
| Jun 2026 | $132.9M | 1.21% |
| Mar 2026 | $131.3M | 4.71% |
| Dec 2025 | $125.4M | 0.45% |
| 32 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| ILMN Illumina, Inc. compare | $154.0M |
| GH Guardant Health, Inc. | $134.4M |
| DGX Quest Diagnostics Incorporated compare | $112.0M |
| RVTY Revvity Inc. compare | $111.8M |
| LH Labcorp Holdings Inc. compare | $81.6M |
| ICLR ICON PLC compare | $77.4M |
| CRL Charles River Laboratories International, Inc. compare | $48.6M |
| MEDP Medpace Holdings, Inc. compare | $28.4M |
| MTD Mettler-Toledo International, Inc. compare | $20.2M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on GH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement